Upside | ||||||
|---|---|---|---|---|---|---|
| 028300 | 21.61% | aa.aa | 55,900 | -1.58% | 57,012 | |
| 196170 | 17.72% | aa.aa | 317,500 | -4.08% | 10,791 | |
| 141080 | 6.14% | aa.aa | 103,100 | +0.78% | 13,161 | |
| 000250 | 5.60% | aa.aa | 148,000 | -1.99% | 7,107 | |
| 087010 | 4.11% | aa.aa | 197,800 | +5.10% | 11,013 | |
| 214450 | 3.94% | aa.aa | 416,000 | +1.46% | 3,187 | |
| 145020 | 3.83% | aa.aa | 346,500 | -1.00% | 2,850 | |
| 328130 | 3.05% | aa.aa | 48,250.00 | -2.92% | 11,742 | |
| 298380 | 2.89% | aa.aa | 60,500 | -1.63% | 16,865 | |
| 310210 | 2.59% | aa.aa | 112,100.00 | +6.76% | 5,468 |
Mirae Asset KOSDAQ150Biotech ETF is an exchange traded fund launched and managed by Mirae Asset Global Investments Co., Ltd. The fund invests in the public equity markets of South Korea. It seeks to invest in the stocks of companies operating in the biotechnology sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the KOSDAQ150 Biotech Index. Mirae Asset KOSDAQ150Biotech ETF was formed on December 15, 2016 and is domiciled in South Korea.